Inverse Association of Plasma Molybdenum with Metabolic Syndrome in a Chinese Adult Population: A Case-Control Study
- PMID: 34960095
- PMCID: PMC8707707
- DOI: 10.3390/nu13124544
Inverse Association of Plasma Molybdenum with Metabolic Syndrome in a Chinese Adult Population: A Case-Control Study
Abstract
Molybdenum has been found to be associated with metabolic disorders. However, the relationship between molybdenum and metabolic syndrome (MetS) is still unclear. A large case-control study was conducted in a Chinese population from the baseline of Ezhou-Shenzhen cohort. A total of 5356 subjects were included with 2678 MetS and 2678 controls matched by sex and age (±2 years). Medians (IQRs) of plasma molybdenum concentrations were 1.24 μg/L for MetS cases and 1.46 μg/L for controls. After adjustment for multiple covariates, the odds ratio (OR) and 95% confidence intervals (CIs) for MetS were 1.00 (reference), 0.71 (0.59-0.84), 0.56 (0.46-0.68), and 0.47 (0.39-0.58) across quartiles of plasma molybdenum, and per SD increment of log-transformed molybdenum was associated with a 23% lower risk of MetS. In the spline analysis, the risk of MetS and its components decreased steeply with increasing molybdenum and followed by a plateau when the cutoff point was observed around 2.0 μg/L. The dose-dependent relationship of molybdenum with MetS remained consistent when considering other essential elements in the Bayesian kernel machine regression (BKMR) model. In our study, higher plasma molybdenum was significantly associated with a lower risk of MetS, as well as its components, in a dose-response manner.
Keywords: case-control study; dose-response relationship; metabolic syndrome; molybdenum.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Associations of multiple plasma metals with the risk of metabolic syndrome: A cross-sectional study in the mid-aged and older population of China.Ecotoxicol Environ Saf. 2022 Feb;231:113183. doi: 10.1016/j.ecoenv.2022.113183. Epub 2022 Jan 13. Ecotoxicol Environ Saf. 2022. PMID: 35032729
-
Diverse Associations of Plasma Selenium Concentrations and SELENOP Gene Polymorphism with Metabolic Syndrome and Its Components.Oxid Med Cell Longev. 2020 Apr 22;2020:5343014. doi: 10.1155/2020/5343014. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32377302 Free PMC article. Clinical Trial.
-
Associations between essential metals exposure and metabolic syndrome (MetS): Exploring the mediating role of systemic inflammation in a general Chinese population.Environ Int. 2020 Jul;140:105802. doi: 10.1016/j.envint.2020.105802. Epub 2020 May 28. Environ Int. 2020. PMID: 32474217
-
Low Serum ZAG Levels Correlate With Determinants of the Metabolic Syndrome in Chinese Subjects.Front Endocrinol (Lausanne). 2020 Mar 24;11:154. doi: 10.3389/fendo.2020.00154. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32265843 Free PMC article.
-
Associations of urinary essential metals and their mixture with metabolic syndrome and its components among Chinese community-dwelling older adults.J Trace Elem Med Biol. 2025 Apr;88:127623. doi: 10.1016/j.jtemb.2025.127623. Epub 2025 Feb 18. J Trace Elem Med Biol. 2025. PMID: 39986121
Cited by
-
Association of plasma zinc and copper levels with mild cognitive impairment in patients with type 2 diabetes.Front Nutr. 2025 Mar 12;12:1532080. doi: 10.3389/fnut.2025.1532080. eCollection 2025. Front Nutr. 2025. PMID: 40144573 Free PMC article.
-
Impact on Glucose Homeostasis: Is Food Biofortified with Molybdenum a Workable Solution? A Two-Arm Study.Nutrients. 2022 Mar 24;14(7):1351. doi: 10.3390/nu14071351. Nutrients. 2022. PMID: 35405964 Free PMC article.
-
Examining the liver-pancreas crosstalk reveals a role for the molybdenum cofactor in β-cell regeneration.Life Sci Alliance. 2024 Aug 19;7(11):e202402771. doi: 10.26508/lsa.202402771. Print 2024 Nov. Life Sci Alliance. 2024. PMID: 39159974 Free PMC article.
-
Association between Dietary Intake, Profibrotic Markers, and Blood Pressure in Patients with Chronic Kidney Disease.Adv Biomed Res. 2024 Apr 27;13:29. doi: 10.4103/abr.abr_204_23. eCollection 2024. Adv Biomed Res. 2024. PMID: 39234436 Free PMC article.
-
Recent advances in the application of ionomics in metabolic diseases.Front Nutr. 2023 Jan 16;9:1111933. doi: 10.3389/fnut.2022.1111933. eCollection 2022. Front Nutr. 2023. PMID: 36726817 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical